PubMed · 2000 · 43 citations · 0 references
Life SciencesMolecular BiologyMolecular GeneticsMolecular DiagnosticsMolecular VirologyVirologyAntiretroviral TherapyHiv DiagnosisHiv TestingNucleic Acid ExtractionNucleic Acid SequencingPolymerase Chain ReactionAssayBlood Nucleic Acid ExtractionCdna SynthesisDirect Rna SequencingHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyNucleic Acid AmplificationRna Extraction
OBJECTIVES: We attempted to define optimal conditions for amplification of low copy number HIV-1 RNA sequences in plasma samples, applying improved conditions for nucleic acid extraction and amplification. METHODS: Several methodologic parameters were evaluated, including methods of RNA extraction, volumes of plasma samples, proportion of extracted RNA used as a template for amplification, and reverse transcriptase-DNA polymerase enzyme combination employed in cDNA synthesis and polymerase chain reaction amplification. RESULTS: With this improved assay, we were able to obtain sufficient amounts of amplified material for direct sequencing in 97% of all plasma samples in our study, including 88% of samples with viral loads <80 copies/mL, 78% of samples with viral loads <50 copies/mL, and even 2 (67%) of 3 samples with <20 copies/mL. CONCLUSIONS: This procedure could be useful for testing resistance mutations in patients undergoing highly active antiretroviral therapy, in which the viral load is commonly <400 copies/mL, and even if it is <20 RNA copies/mL.